Clinical trial
Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult…
NCT00191360 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191360 |
|---|---|
| Title | Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency |
| Official title | Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adult Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Somatropin |
| Enrollment | 68 |
| Start date | Jan 1, 2003 |
| Completion | May 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 6, 2007 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: